Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus

(E-pub Ahead of Print)

Author(s): Mohammad Reza Rahbar, Hadi Esmaeili Gouvarchin Galeh, Saeed Khalili, Abolfazl Jahangiri*

Journal Name: Letters in Drug Design & Discovery

Become EABM
Become Reviewer
Call for Editor


The recent pandemic caused by a novel coronavirus known as SARS-CoV-2 has caught the international community by surprise. There is still no effective vaccine or treatment option against this virus. In this perspective, we discussed potential protective and therapeutic effects of chitosan, as an FDA-approved biomolecule, against COVID-19 and influenza viruses.

Keywords: Chitosan, COVID-19, Immune response, Innate Immunity, Biotherapeutic, Macromolecule

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1570180817999201110114446
Price: $95

Article Metrics

PDF: 3